Human medicines European public assessment report (EPAR): Ponvory, ponesimod, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 19/05/2021, Status: Authorised

SEMrush
Human medicines European public assessment report (EPAR): Ponvory, ponesimod, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 19/05/2021, Status: Authorised
[automaticbacklinks]